Chronic Respiratory Infections

A special issue of Pathogens (ISSN 2076-0817).

Deadline for manuscript submissions: closed (4 July 2023) | Viewed by 2447

Special Issue Editor


E-Mail Website
Guest Editor
State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou 510089, China
Interests: allergic diseases; asthma; COPD; interstitial pneumonia; immunological mechanism and immunological diagnosis of respiratory diseases; COVID-19

Special Issue Information

Dear Colleagues,

Chronic respiratory disease is a group of disorders that primarily affect the lungs and airways. In addition to chronic obstructive pulmonary disease (COPD) and asthma, chronic respiratory diseases include interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis. Due in great part to the prevalence of harmful environmental, occupational, and behavioral inhalational exposures, chronic respiratory diseases are among the most prevalent non-communicable diseases worldwide and are a prominent cause of global morbidity and mortality. The World Health Organization (WHO) estimates that 4.6 million people die prematurely each year as a result of chronic respiratory disease, accounting for more than 5% of global deaths; almost 90% of these occur in low- and middle-income countries. Unfortunately, compared to other major diseases such as cancer and cardiovascular disease, chronic respiratory diseases have received relatively less public attention and research funding. Therefore, it is essential that we pay more attention to researching chronic respiratory disease. 

Prof. Dr. Baoqing Sun
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • chronic respiratory disease
  • COPD
  • asthma
  • non-communicable disease
  • ILD

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

25 pages, 1070 KiB  
Review
Diagnosis and Treatment of Fungal Infections in Lung Transplant Recipients
by Jesus E. Escamilla, Spenser E. January and Rodrigo Vazquez Guillamet
Pathogens 2023, 12(5), 694; https://doi.org/10.3390/pathogens12050694 - 10 May 2023
Cited by 2 | Viewed by 2184
Abstract
Fungal infections are a significant source of morbidity in the lung transplant population via direct allograft damage and predisposing patients to the development of chronic lung allograft dysfunction. Prompt diagnosis and treatment are imperative to limit allograft damage. This review article discusses incidence, [...] Read more.
Fungal infections are a significant source of morbidity in the lung transplant population via direct allograft damage and predisposing patients to the development of chronic lung allograft dysfunction. Prompt diagnosis and treatment are imperative to limit allograft damage. This review article discusses incidence, risk factors, and symptoms with a specific focus on diagnostic and treatment strategies in the lung transplant population for fungal infections caused by Aspergillus, Candida, Coccidioides, Histoplasma, Blastomyces, Scedosporium/Lomentospora, Fusarium, and Pneumocystis jirovecii. Evidence for the use of newer triazole and inhaled antifungals to treat isolated pulmonary fungal infections in lung transplant recipients is also discussed. Full article
(This article belongs to the Special Issue Chronic Respiratory Infections)
Show Figures

Figure 1

Back to TopTop